All Stories

  1. Cophenetic Spatial Topology Embedding reveals multiscale tissue architecture in spatial omics
  2. Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironment
  3. gSV: a general structural variant detector using the third-generation sequencing data
  4. Targeted sequencing of mutations via RNA-templated gap filling of oligonucleotides for single-cell RNA-seq
  5. gSV: a general structural variant detector using the third-generation sequencing data
  6. FreqPath-Net: Frequency-Aware Spectral–Orthogonal Network for Histopathological Nuclei Segmentation
  7. Direct Inference of Haplotypes from Sequencing Data
  8. Comparing Xenium 5K and Visium HD data from identical tissue slide at a pathological perspective
  9. Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows
  10. Imaging flow cytometry with a real-time throughput beyond 1,000,000 events per second
  11. MRRM: Advanced Biomarker Alignment in Multi-Staining Pathology Images via Multi-Scale Ring Rotation-Invariant Matching
  12. BVSim: A benchmarking variation simulator mimicking human variation spectrum
  13. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple‐Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  14. cascAGS: Comparative Analysis of SNP Calling Methods for Human Genome Data in the Absence of Gold Standard
  15. CellSAM: Advancing Pathologic Image Cell Segmentation via Asymmetric Large‐Scale Vision Model Feature Distillation Aggregation Network
  16. Proteomics Landscape of Triple-Negative Apocrine Breast Carcinoma Reveals Molecular Mechanisms of Tumorigenesis and Characteristics of Chemo-insensitivity
  17. Bridging Discoveries and Treatments: The New Landscape of Breast Cancer Research
  18. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple-Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  19. MSGM: An Advanced Deep Multi-Size Guiding Matching Network for Whole Slide Histopathology Images Addressing Staining Variation and Low Visibility Challenges
  20. Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification
  21. An orientation-free ring feature descriptor with stain-variability normalization for pathology image matching
  22. Author Correction: The landscape of viral associations in human cancers
  23. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes
  24. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  25. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  26. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  27. Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  28. Author Correction: Pan-cancer analysis of whole genomes
  29. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  30. Author Correction: Genomic basis for RNA alterations in cancer
  31. Author Correction: Patterns of somatic structural variation in human cancer genomes
  32. Author Correction: The evolutionary history of 2,658 cancers
  33. Author Correction: The repertoire of mutational signatures in human cancer
  34. Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
  35. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  36. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower
  37. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
  38. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
  39. Author Correction: Inferring structural variant cancer cell fraction
  40. Author Correction: Integrative pathway enrichment analysis of multivariate omics data
  41. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
  42. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  43. Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  44. Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  45. Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
  46. Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
  47. Assessment of accuracy in identifying structural variants using third-generation sequencing for breast cancer in the absence of gold standard
  48. AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
  49. Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study
  50. Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
  51. Tunable mechanical and degradation properties of biodegradable Mg-Y-Zn alloys via Zn content regulation
  52. HER2-low-positive features a distinct subtype in estrogen receptor-positive breast cancer associated with endocrine therapy resistance
  53. Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
  54. BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images
  55. Androgen receptor expression associates with distinctive clinicopathological and molecular features in ER-positive and ER-negative breast cancer
  56. Intraparenchymal breast leiomyoma and atypical leiomyoma
  57. Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing
  58. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  59. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
  60. The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
  61. Triple negative apocrine breast carcinoma has better prognosis despite poor response to neoadjuvant chemotherapy
  62. Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database
  63. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  64. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  65. Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia
  66. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  67. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  68. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  69. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  70. Intraparenchymal Breast Leiomyoma and Atypical Leiomyoma
  71. Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
  72. Prognosis classification of breast cancer with distant lymph node metastasis IIIc or M1 category
  73. Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients
  74. A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
  75. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
  76. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
  77. RECQL5 KIX domain splicing isoforms have distinct functions in transcription repression and DNA damage response
  78. A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes
  79. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  80. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  81. Sex differences in oncogenic mutational processes
  82. Highly Recurrent Copy Number Variations in GABRB2 Associated With Schizophrenia and Premenstrual Dysphoric Disorder
  83. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  84. Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  85. Detecting viruses in tumour tissue to discover links between cancer and infection
  86. Inferring structural variant cancer cell fraction
  87. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  88. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  89. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  90. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  91. Combined burden and functional impact tests for cancer driver discovery using DriverPower
  92. Divergent mutational processes distinguish hypoxic and normoxic tumours
  93. Genomic footprints of activated telomere maintenance mechanisms in cancer
  94. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  95. Integrative pathway enrichment analysis of multivariate omics data
  96. Pathway and network analysis of more than 2500 whole cancer genomes
  97. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  98. Comprehensive molecular characterization of mitochondrial genomes in human cancers
  99. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  100. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  101. Butler enables rapid cloud-based analysis of thousands of human genomes
  102. Genomic basis for RNA alterations in cancer
  103. Patterns of somatic structural variation in human cancer genomes
  104. The repertoire of mutational signatures in human cancer
  105. Pan-cancer analysis of whole genomes
  106. The evolutionary history of 2,658 cancers
  107. Genomic subtyping of liver cancers with prognostic application
  108. Natural History of Breast Cancer: Reanalyze Nodal Stage and Oestrogen Receptor Status Affecting the Progression of Breast Cancer from SEER Database
  109. Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10
  110. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database
  111. AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data
  112. Forward and reverse mutations in stages of cancer development
  113. Forward-reverse mutation cycles between stages of cancer development
  114. Coevolution Theory of the Genetic Code at Age Forty: Pathway to Translation and Synthetic Life
  115. Tripartite genome of all species
  116. Feature co-localization landscape of the human genome
  117. GABRB2 Haplotype Association with Heroin Dependence in Chinese Population
  118. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
  119. The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later